Company Overview and News


Add 524816
to your dashboard

Headline News

Natco Pharma Limited - Committee Meeting Updates

23h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Natco Pharma raises Rs 915 crore via QIP

2017-12-14 moneycontrol
Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors, according to a regulatory filing.

Sensex gains 194 pts as all eyes on Gujarat exit polls; all sectoral indices up

2017-12-14 moneycontrol
Equity benchmarks rebounded sharply in last hour of trade Thursday despite weak global cues, as investors awaited exit polls after the end of second phase of Gujarat assembly elections later today. This will give some indication towards actual results of state elections which will be declared on December 18. (23-0)

Natco Pharma Limited - Qualified Institutional Placement

2017-12-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Natco Pharma Limited - Committee Meeting Updates

2017-12-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Market Update: TCS, UPL fall 2%, Glenmark Pharma hits 52-week low; Tata Comm, RIL most active

2017-12-14 moneycontrol
The Indian benchmark indices on Thursday afternoon were trading on a negative note with the Nifty up 19 points or 0.19 percent while the Sensex shedding 80 points and was trading at 32972. (9-0)

Market Update: Tech Mahindra, Dr Reddy#39;s top gainers, Tata Comm up 4%; TCS, Maruti most active

2017-12-14 moneycontrol
The Indian benchmark indices on Thursday morning were trading on a positive note with the Nifty up 12 points or 0.12 percent while the Sensex added 31 points and was trading at 33083. (9-0)

Natco Pharma Limited - Shareholders meeting

2017-11-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Hep-C, Cancer and Hemophilia drugs to cost less as regulator caps prices of 51 formulations

2017-11-24 moneycontrol
The national drug price regulator on Friday fixed the ceiling price of 51 more drug formulations that include vaccines and medicines to treat hepatitis-C, kidney diseases, hemophilia B, cardiac problems and cancers making them much cheaper than the prevailing market prices. (2-0)

For growth, Natco Pharma to focus on complex drugs, novel delivery systems

2017-11-14 thehindubusinessline
Natco Pharma plans to step up focus on high potential filings and differentiated products in the complex generics segment for exports as part of its growth strategy.

Natco picks stake in OMRV Hospitals

2017-11-07 thehindubusinessline
Natco Pharma has executed definitive agreement and subscribed to 7.50 per cent of the paid-up equity share capital of OMRV Hospitals Pvt Ltd (OMRV) at investment of ₹7.50 crore.

Cipla shares tank over 7%, market cap tanks Rs3,785.5 crore

2017-11-07 livemint
New Delhi: Shares of Cipla on Tuesday slumped over 7% even as the company reported a consolidated net profit of Rs434.95 crore for the second quarter ended September. The stock dropped 7.18% to end at Rs608.35 on BSE.

Natco Pharma Limited - Investor Presentation

2017-11-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Natco Pharma invests Rs 7.5 cr in PACE Hospital

2017-11-04 thehindubusinessline
Natco Pharma today said it has invested Rs 7.5 crore to pick up 7.5 per cent stake in OMRV Hospitals.

Natco Pharma invests Rs 7.5 cr in Hyderabad#39;s PACE Hospital

2017-11-04 moneycontrol
Natco Pharma today said it has invested Rs 7.5 crore to pick up 7.5 per cent stake in OMRV Hospitals.